COMMUNIQUÉS West-GlobeNewswire

L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.
03/09/2026
Cette recommandation constitue une étape importante vers un éventuel remboursement public pour les adultes admissibles dont l’hypoparathyroïdie chronique n’est pas adéquatement maîtrisée par le traitement conventionnel [...]
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
03/09/2026
Recommendation is an important step toward potential public reimbursement for eligible adults whose chronic hypoparathyroidism is not adequately controlled with conventional therapy MONTREAL, Sept. 03, 2026 (GLOBE [...]
Vivani Medical Announces Participation in Upcoming Investor Conferences
03/09/2026
ALAMEDA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants [...]
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
03/09/2026
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare [...]
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
03/09/2026
Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union AUDUBON, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal [...]
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
03/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/09/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 03 sept. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
03/09/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre
03/09/2026
Châtillon, France, le 3 septembre (22 :30 CEST) 2026 DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock [...]
DBV Technologies to Participate in Upcoming September Investor Conferences
03/09/2026
Châtillon, France, September 3, 2026 DBV Technologies to Participate in Upcoming September Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “ Company ”), a late [...]
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
03/09/2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee. Effective September 1, 2026, in [...]
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
03/09/2026
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek [...]
Progyny, Inc. to Present at the Wells Fargo Healthcare Conference
03/09/2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present [...]
FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats
03/09/2026
Silver Spring, Md, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, [...]
Ipsen - Août 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/09/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Ipsen - August 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
03/09/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
GENFIT organise un événement virtuel avec un leader d’opinion (KOL) consacré au diagnostic de la MASH le 9 septembre 2026
03/09/2026
Les présentations mettront en avant l’utilité clinique et le potentiel commercial à long terme de la plateforme propriétaire NIS de GENFIT, une technologie de diagnostic non invasive pour la MASH Lille (France), [...]
GENFIT to Host Virtual KOL Event Focused on MASH Diagnostics on September 9, 2026
03/09/2026
Presentations will highlight the clinical utility and long-term commercial opportunity of GENFIT’s proprietary NIS platform, a non-invasive diagnostic technology for MASH Lille (France), Cambridge (Massachusetts, United [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
03/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]

Pages